Alpha-1 Adrenergic Antagonists Sensitize Neuroblastoma to Therapeutic Differentiation.

MLA

Broso, Francesca, et al. “Alpha-1 Adrenergic Antagonists Sensitize Neuroblastoma to Therapeutic Differentiation.” Cancer Research, vol. 83, no. 16, Aug. 2023, pp. 2733–49. EBSCOhost, https://doi.org/10.1158/0008-5472.CAN-22-1913.

APA

Broso, F., Gatto, P., Sidarovich, V., Ambrosini, C., De Sanctis, V., Bertorelli, R., Zaccheroni, E., Ricci, B., Destefanis, E., Longhi, S., Sebastiani, E., Tebaldi, T., Adami, V., & Quattrone, A. (2023). Alpha-1 Adrenergic Antagonists Sensitize Neuroblastoma to Therapeutic Differentiation. Cancer Research, 83(16), 2733–2749. https://doi.org/10.1158/0008-5472.CAN-22-1913

Chicago

Broso, Francesca, Pamela Gatto, Viktoryia Sidarovich, Chiara Ambrosini, Veronica De Sanctis, Roberto Bertorelli, Elena Zaccheroni, et al. 2023. “Alpha-1 Adrenergic Antagonists Sensitize Neuroblastoma to Therapeutic Differentiation.” Cancer Research 83 (16): 2733–49. doi:10.1158/0008-5472.CAN-22-1913.